Vir Biotechnology
VIR
Reported
Thursday, February 23
Q4 2022 Earnings
| (USD) | Expected | Reported | Surprise $ | Surprise % |
|---|---|---|---|---|
| EPS | -0.39 | -0.76 | -0.37 | -94.87% |
| Revenue | 97.3M | 49.4M | -47.9M | -49.22% |
WhatIF - Earnings
EPS Missed Expectations by -$0.37
Vir Biotechnology (VIR:NASDAQ) has never missed EPS by this much before
There’s a first time for everything